FDA Inspection 1300064 — Octapharma Plasma Inc
The FDA completed an inspection of Octapharma Plasma Inc on Jan 16, 2026 in Kansas City, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 16, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Kansas City, KS (United States)
Need the full FDA record for Octapharma Plasma Inc? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.